Department of Internal Medicine and Cardiology, Charité - Universitätsmedizin Berlin, Campus Virchow Klinikum, Berlin, Germany.
Department of Internal Medicine and Cardiology, German Heart Institute Berlin (DHZB), Berlin, Germany.
ESC Heart Fail. 2022 Dec;9(6):4120-4128. doi: 10.1002/ehf2.14131. Epub 2022 Sep 7.
Although the number of patients suffering from heart failure with preserved ejection fraction (HFpEF) increases, the routine diagnosis remains a challenge. In the absence of a pathognomonic sign for HFpEF or specific treatment strategies, a prognosis-based characterization of suspected patients remains promising for both the risk stratification of the patients and a disease definition. The Heart Failure Association (HFA) of the European Society of Cardiology has introduced an algorithm with different levels of likelihood regarding the diagnosis of HFpEF, the HFA-PEFF score. We aimed to evaluate the predictive value of this algorithm in a large cohort regarding mortality, symptom burden, and the functional status.
DIAST-CHF is a multicentre, population-based, prospective, observational study in subjects with at least one risk factor for HFpEF between the age of 50 and 85. We calculated the HFA-PEFF score (n = 1668) and analysed the risk groups for overall mortality, cardiovascular hospitalization, and submaximal functional capacity (6-min walk distance) at baseline and after a follow-up period of 10 years. Patients with high HFA-PEFF score values 5&6 showed a higher mortality than those with an intermediate score (score values 2-4) and low score values (high 21.3% vs. intermediate 10.1% vs. low 4.3%, P < 0.001). Also, the burden of MACE (death, cardiovascular hospitalization, new myocardial infarction, first diagnosis of HF) was increased in the high score values group (high 40.7% vs. intermediate 25.9% vs. low 13.9%, P < 0.001). Similarly, patients with higher scores had higher cumulative incidences of cardiovascular hospitalizations (P = 0.011). Subjects with higher scores also had lower 6-min walk distance both at baseline and during follow-up.
The HFA-PEFF score provides a reliable instrument to stratify suspected HFpEF patients by their risk for mortality, symptom burden, and functional status in cohort at risk with a follow-up period of 10 years. As high HFA-PEFF scores are associated with worse outcome, the HFA-PEFF algorithm describes a defining approach towards HFpEF.
尽管射血分数保留型心力衰竭(HFpEF)患者人数不断增加,但常规诊断仍然具有挑战性。在缺乏 HFpEF 特异性诊断标志物或特定治疗策略的情况下,对疑似患者进行基于预后的特征描述对于患者风险分层和疾病定义都具有重要意义。欧洲心脏病学会心力衰竭协会(HFA)引入了一种具有不同可能性的 HFpEF 诊断算法,即 HFA-PEFF 评分。我们旨在评估该算法在一个大型队列中对死亡率、症状负担和功能状态的预测价值。
DIAST-CHF 是一项多中心、基于人群的前瞻性观察性研究,纳入年龄在 50 至 85 岁之间至少存在一个 HFpEF 危险因素的受试者。我们计算了 HFA-PEFF 评分(n=1668),并分析了基线时和 10 年随访期间全因死亡率、心血管住院和亚最大运动能力(6 分钟步行距离)的风险组。高 HFA-PEFF 评分值 5&6 的患者死亡率高于中值评分(评分值 2-4)和低值评分(高 21.3% vs. 中值 10.1% vs. 低 4.3%,P<0.001)。此外,高评分值组的主要不良心血管事件(死亡、心血管住院、新发心肌梗死、HF 首次诊断)负担增加(高 40.7% vs. 中值 25.9% vs. 低 13.9%,P<0.001)。同样,较高评分值的患者心血管住院的累积发生率更高(P=0.011)。评分较高的患者在基线和随访期间的 6 分钟步行距离也较低。
HFA-PEFF 评分可用于根据死亡率、症状负担和功能状态对疑似 HFpEF 患者进行风险分层,在具有 10 年随访期的高危队列中具有较高的可靠性。由于高 HFA-PEFF 评分与较差的预后相关,HFA-PEFF 算法描述了一种定义 HFpEF 的方法。